e-learning
resources
Munich 2014
Sunday, 07.09.2014
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate
O. Drozdovszky, B. Antus (Budapest, Hungary)
Source:
International Congress 2014 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster Session
Number:
993
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Drozdovszky, B. Antus (Budapest, Hungary). Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate. Eur Respir J 2014; 44: Suppl. 58, 993
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Markers of inflammation in exhaled breath condensate and bronchoalveolar lavage fluid
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Markers of fibrosis in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) in sarcoidosis
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Surfactant protein A in particles in exhaled air (PEx) – A better reflection of small airways in comparison to bronchoalveolar lavage and serum?
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults
Source: Eur Respir J 2007; 30: 769-781
Year: 2007
Cytokine and chemokine composition of bronchoalveolar lavage fluid and exhaled breath condensate of healthy individuals
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Nasal lavage cysteinyl-leukotrienes correlate with exhaled breath condensate in children
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006
Is analysis of exhaled breath condensate equivalent to that of bronchoalveolar lavage fluid?
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004
Distribution of surfactant proteins in proximal and distal airways
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Indices of oxidative stress in a feline model of asthma: 8-Iso-PGF
2α
in bronchoalveolar lavage and H
2
O
2
in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004
Expired breath condensate H
2
O
2
correlates with bronchoalveolar lavage neutrophilia
Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Year: 2003
Exhaled particles as markers of small airways inflammation in asthmatic subjects
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO
Source: Eur Respir J 2004; 24: Suppl. 48, 578s
Year: 2004
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Exhaled breath condensate pH in exercise-induced bronchoconstriction
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Electronic nose breathprints reflect BALF inflammatory cell counts in asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Extracellular purines are biomarkers of neutrophilic airway inflammation
Source: Eur Respir J 2008; 31: 949-956
Year: 2008
Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept